Advertisement
Screener

Celldex Therapeutics, Inc. (CLDX) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

2.5 / 5 stars · 46/91 Roast Me

Celldex Therapeutics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

Celldex Therapeutics, Inc. (CLDX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 11.43 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06

  • Celldex Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 9.07M shares, a 20.97% increase year-over-year.
  • Celldex Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 7.50M shares, a 21.76% increase year-over-year.
  • Celldex Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 6.16M shares, a 23.97% increase year-over-year.
  • Celldex Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 4.97M shares, a 22.22% increase year-over-year.
  • Celldex Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 4.08M shares, a 34.04% increase from fiscal 2020.
  • Celldex Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2020 was 3.04M shares, a 78.92% increase from fiscal 2019.
  • Celldex Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2019 was 1.70M shares, a 95.51% increase from fiscal 2018.
  • Celldex Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2018 was 869.68K shares, a 19.10% increase from fiscal 2017.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2026-06-3011.43M shares
10-Q · filed 2026-08-06
2026-03-319.07M shares
10-Q · filed 2026-05-07
2025-09-309.18M shares
10-Q · filed 2025-11-10
2025-06-309.29M shares
10-Q · filed 2026-08-06
2025-03-317.50M shares
10-Q · filed 2026-05-07
2024-09-307.53M shares
10-Q · filed 2025-11-10
2024-06-307.53M shares
10-Q · filed 2025-08-07
2024-03-316.16M shares
10-Q · filed 2025-05-08
2023-09-306.41M shares
10-Q · filed 2024-11-06
2023-06-306.45M shares
10-Q · filed 2024-08-08
2023-03-314.97M shares
10-Q · filed 2024-05-06
2022-12-314.06M shares
10-Q · filed 2022-05-05
2022-09-305.19M shares
10-Q · filed 2023-11-02
2022-06-305.59M shares
10-Q · filed 2023-08-08
2022-03-314.06M shares
10-Q · filed 2023-05-04
2021-12-314.08M shares
10-K · filed 2022-02-28
2021-09-304.13M shares
10-Q · filed 2022-11-09
2021-06-304.34M shares
10-Q · filed 2022-08-08
2021-03-313.05M shares
10-Q · filed 2022-05-05
2020-12-313.04M shares
10-K · filed 2022-02-28
2020-09-303.07M shares
10-Q · filed 2021-11-09
2020-06-303.09M shares
10-Q · filed 2021-08-05
2020-03-311.66M shares
10-Q · filed 2021-05-06
2019-12-311.70M shares
10-K · filed 2022-02-28
2019-09-301.73M shares
10-Q · filed 2020-11-05
2019-06-301.69M shares
10-Q · filed 2020-08-06
2019-03-31839.66K shares
10-Q · filed 2020-05-06
2018-12-31869.68K shares
10-K · filed 2021-03-29
2018-09-30886.67K shares
10-Q · filed 2019-11-12		13.30M shares
10-Q · filed 2018-11-07
2018-06-30935.08K shares
10-Q · filed 2019-08-07		14.03M shares
10-Q · filed 2018-08-08
2018-03-31636.89K shares
10-Q · filed 2019-05-07		9.55M shares
10-Q · filed 2018-05-10
2017-12-31730.19K shares
10-K · filed 2020-03-26		10.95M shares
10-K · filed 2018-03-07
2017-09-3011.68M shares
10-Q · filed 2018-11-07
2017-06-3012.19M shares
10-Q · filed 2018-08-08
2017-03-3110.21M shares
10-Q · filed 2018-05-10
2016-12-31684.58K shares
10-K · filed 2019-03-07		10.27M shares
10-K · filed 2017-03-14
2016-09-3010.21M shares
10-Q · filed 2017-11-07
2016-06-3010.32M shares
10-Q · filed 2017-08-08
2016-03-318.17M shares
10-Q · filed 2017-05-09
2015-12-318.13M shares
10-K · filed 2018-03-07
2015-09-308.13M shares
10-Q · filed 2016-11-07
2015-06-308.16M shares
10-Q · filed 2016-08-08
2015-03-316.54M shares
10-Q · filed 2016-05-05
2014-12-317.02M shares
10-K · filed 2017-03-14
2014-09-307.01M shares
10-Q · filed 2014-11-05		7.01M shares
10-Q · filed 2015-11-05		6.09M shares
10-Q · filed 2014-11-05
2014-06-306.97M shares
10-Q · filed 2015-08-10
2014-03-315.67M shares
10-Q · filed 2015-04-29
2013-12-315.78M shares
10-K/A · filed 2016-02-25
2013-09-306.09M shares
10-Q · filed 2013-11-08		6.09M shares
10-Q · filed 2013-11-08
2013-06-305.02M shares
10-Q · filed 2014-08-07
2013-03-315.09M shares
10-Q · filed 2014-05-01
2012-12-315.36M shares
10-K · filed 2015-02-24
2012-09-305.36M shares
10-Q · filed 2013-11-08		5.36M shares
10-Q · filed 2013-11-08
2012-06-304.32M shares
10-Q · filed 2013-08-06
2012-03-314.31M shares
10-Q · filed 2013-05-03
2011-12-314.47M shares
10-K · filed 2014-03-03
2011-09-304.54M shares
10-Q · filed 2012-11-02
2011-06-303.73M shares
10-Q · filed 2012-08-09
2010-12-314.38M shares
10-K · filed 2013-03-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEOGEN CORP (NEOG)United States$2.979B-247.49
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Advertisement